Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now displays a 403 Forbidden error indicating restricted access to the record. The new content includes the 403 header, a minimal HTML snippet declaring the error, a Home link, and a revision note.SummaryDifference18%

- Check36 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, signaling a small patch to the study record. No substantive content or study details appear to be altered.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, indicating a minor platform update and not altering the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a maintenance update. The study details on the page appear unchanged.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page's revision/version label was updated from v3.6.2 to v3.6.3, reflecting a minor update to the page's metadata.SummaryDifference0.1%

- Check100 days agoChange DetectedThe site revision was updated from v3.6.0 to v3.6.2, reflecting a platform-level update rather than changes to the study details displayed on the page.SummaryDifference0.1%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.